Open interest: Calls 408 vs Puts 55 → very low OI put/call (0.13) typically leans bullish, but may also reflect thin/one-sided positioning.
Volume: Today’s options volume is 0 (calls 0, puts 0) → sentiment read is low confidence due to no active participation.
Volatility: 30D IV ~79.49% vs historical volatility ~22.39% → options are pricing large moves relative to realized; often seen ahead of event risk or with illiquidity.
IV percentile 83.67 → elevated vs its own history, suggesting options are expensive.
Technical Summary
Sell
4
Buy
9
Positive Catalysts
and pushes through ~15.74.
Neutral/Negative Catalysts
Technicals are currently stacked against a quick entry: bearish MA structure + worsening MACD.
Pattern-based near-term expectation is negative (next week skew).
Elevated implied volatility with no volume suggests fragile liquidity/price discovery; downside can gap through supports if sellers press.
Macro tape is risk-off today (S&P 500 -0.93%), which can pressure smaller-cap names.
No analyst rating or price target change data was provided, so a clear “Wall Street” consensus trend cannot be confirmed from this dataset.
Practical read-through from available data: with weakening YoY growth metrics and a bearish chart, the “pro” case would likely rely on an earnings turnaround catalyst, while the “con” case centers on declining revenue/earnings and continued technical downtrend.
Politicians/influential figures: no recent congress trading data available; no politician buy/sell signal identified here.
Wall Street analysts forecast MCS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MCS is 23.5 USD with a low forecast of 22 USD and a high forecast of 25 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast MCS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MCS is 23.5 USD with a low forecast of 22 USD and a high forecast of 25 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 15.210
Low
22
Averages
23.5
High
25
Current: 15.210
Low
22
Averages
23.5
High
25
Wedbush
Outperform
initiated
$24
AI Analysis
2025-07-18
Reason
Wedbush
Price Target
$24
AI Analysis
2025-07-18
initiated
Outperform
Reason
Wedbush initiated coverage of Marcus with an Outperform rating and $24 price target. The firm sees the company benefiting from a more consistent theatrical release slate over the next several quarters. Marcus is positioned to to raise its dividend back toward pre-pandemic rates and repurchase shares, the analyst tells investors in a research note. Wedbush adds that Marcus has room to monetize surplus real estate as it owns most of its properties. It has a positive bias on the shares.
B. Riley
B. Riley
Buy
downgrade
$26 -> $24
2025-05-16
Reason
B. Riley
B. Riley
Price Target
$26 -> $24
2025-05-16
downgrade
Buy
Reason
B. Riley lowered the firm's price target on Marcus to $24 from $26 and keeps a Buy rating on the shares following a transfer of coverage. The firm is "generally constructive" on the exhibitor space, saying the sector is underpinned by a strong Hollywood film slate for 2025 and 2026 that should fuel further box office recovery and benefit relevant industry participants. Riley also finds limited tariff risk and a history of movie-going resiliency during periods of economic weakness "to be additional market themes that are supportive of this favorable backdrop." The firm's top pick across the group is Imax (IMAX), followed by Marcus (MCS).
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MCS
